Ilika’s defence testing opens a new angle on solid-state battery value

Ilika Plc

Ilika’s latest update adds a different dimension to the investment case around its solid-state battery technology. Rather than focusing solely on future automotive or industrial uses, the company has highlighted how its large-format Goliath cells performed in defence-related testing designed to reflect battlefield conditions.

The key point from the testing is that a 10Ah Goliath cell was able to withstand an initial ballistic impact, with a thermal event only taking place after a second shot Battery developers often face a long path from laboratory promise to commercial credibility, particularly when safety is part of the core sales argument. Evidence that a cell can tolerate severe physical abuse without an immediate worst-case outcome may help support Ilika’s claim that solid-state chemistry can offer a more resilient safety profile in environments where failure tolerance is critical.

Any application where batteries are exposed to physical stress, operational uncertainty or strict safety thresholds could benefit from validation of this kind. Demonstrating a measured response under impact could therefore improve Ilika’s commercial conversation in sectors where risk management carries as much weight as raw battery capability.

Ilika plc (LON:IKA) is a pioneer in solid state battery technology enabling solutions for applications in Industrial IoT, MedTech, Electric Vehicles and Consumer Electronics.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika CEO Graeme Purdy discusses Stereax revenues and Goliath opportunities

Ilika CEO Graeme Purdy discusses first Stereax revenues, grant support for Goliath, EV market trends, and opportunities in defence and e-bikes.

Ilika positions solid state batteries for the future of implantable neurostimulation

Ilika’s Stereax solid state battery technology supports the development of smaller, safer and more practical implantable neurostimulation devices for emerging medical applications.

Ilika advances manufacturing readiness for solid-state batteries

Ilika’s collaboration with UKBIC shows how manufacturing validation is helping move its Goliath pouch cell technology closer to commercial readiness.

Ilika reports first Stereax revenues and Goliath progress

Ilika expects FY26 revenue of approximately £1.1m, including first commercial Stereax electrode sales, with Goliath evaluation activity expanding across automotive, defence and e-bike applications.

Defence battery demand highlights strategic opening for Ilika

Ilika highlights how rising defence and energy security demands are expanding the commercial opportunity for advanced battery technologies across military and infrastructure markets.

Search